Strand offers clinical research and development services to pharmaceutical and biotechnology companies in the areas of clinical trial management, biomarker discovery, and validation. Led by a team of specialist oncopathologists, molecular biologists, and clinical researchers, we are well-positioned to leverage the wide variety of patient cases.
The molecular research department undertakes sponsored research projects for pharmaceutical and biotechnology companies relating to the discovery and validation of cancer biomarkers. We manage an annotated biorepository of clinical specimens, including cancer tumour tissue (and in most cases, paired normal tissue), blood and serum. In many cases, we also maintain clinical data for patients, all in full compliance with norms of good clinical practice and as per protocols approved by our central ethics committee. Our clinical research team works with physicians to determine the genetic profile of different types of cancer to formulate personalized therapeutic approaches, which enable the effective delivery of quality cancer care.